Common Stock (Tables)
|
12 Months Ended |
Dec. 31, 2016 |
|---|
| Summary Of Issuances |
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31,
|
|
|
|
2016
|
2015
|
|
2014
|
|
Compensatory shares issued
|
|
330,000
|
|
150,000
|
|
400,000
|
|
Aggregate market value
|
$
|
97,649
|
$
|
102,000
|
$
|
409,000
|
|
| Schedule Of Stock Option And Stock Warrant Exercises |
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31,
|
|
|
|
2016
|
2015
|
|
2014
|
|
Stock Option Exercises
|
|
|
|
|
|
|
|
Number of shares issued
|
|
-
|
|
889,428
|
|
448,693
|
|
Total cash received
|
$
|
-
|
$
|
708,617
|
$
|
258,955
|
|
|
|
|
|
|
|
|
|
Stock Warrant Exercises
|
|
|
|
|
|
|
|
Number of shares issued
|
|
-
|
|
47,300
|
|
11,738,220
|
|
Total cash received
|
$
|
-
|
$
|
22,325
|
$
|
5,947,268
|
|
| January 21, 2014 Financing [Member] |
|
| Summary Of Allocation Of Proceeds From Offering |
|
|
|
|
|
|
Gross Proceeds:
|
|
$
|
20,000,001
|
|
|
|
|
|
|
Allocated to warrant liabilities:
|
|
|
3,691,429
|
|
Allocated to common stock and additional paid-in capital
|
|
|
16,308,572
|
|
|
|
|
|
|
Total allocated gross proceeds:
|
|
$
|
20,000,001
|
|
| November 12, 2015 Financing [Member] |
|
| Summary Of Allocation Of Proceeds From Offering |
|
|
|
|
|
|
Gross Proceeds:
|
|
$
|
7,000,000
|
|
|
|
|
|
|
Allocated to warrant liabilities:
|
|
|
2,792,500
|
|
Allocated to common stock and additional paid-in capital
|
|
|
4,207,500
|
|
|
|
|
|
|
Total allocated gross proceeds:
|
|
$
|
7,000,000
|
|
| March 2, 2016 Financing [Member] |
|
| Summary Of Allocation Of Proceeds From Offering |
|
|
|
|
|
|
|
|
|
|
|
Gross Proceeds:
|
|
$
|
5,000,000
|
|
|
|
|
|
|
Allocated to warrant liabilities:
|
|
|
2,419,922
|
|
Allocated to common stock and additional paid-in capital
|
|
|
2,580,078
|
|
|
|
|
|
|
Total allocated gross proceeds:
|
|
$
|
5,000,000
|
|
| September 19, 2016 Financing [Member] |
|
| Summary Of Allocation Of Proceeds From Offering |
|
|
|
|
|
|
|
|
|
|
|
Gross Proceeds:
|
|
$
|
6,000,000
|
|
|
|
|
|
|
Allocated to warrant liabilities:
|
|
|
1,671,120
|
|
Allocated to common stock and additional paid-in capital
|
|
|
4,328,880
|
|
|
|
|
|
|
Total allocated gross proceeds:
|
|
$
|
6,000,000
|
|